SCHEMBL16181767

SCHEMBL16181767

CN[C@@H](c1ccccc1)[C@@H](C)CN1CCCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.45
NPC1 O15118 1/20 0.44
LTA4H P09960 1/20 0.43
ALDH1A1 P00352 2/20 0.42
GFER P55789 2/20 0.42
MITF O75030 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
PAX8 Q06710 1/20 0.42
ATM Q13315 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KDM4E B2RXH2 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
UGCG Q16739 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SMYD3 Q9H7B4 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
HIF1A Q16665 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13559344 0.98 POLB (0.46) POLBNPC1LTA4HALDH1A1GFER
SCHEMBL13559350 0.87 GAA (0.51) POLBALDH1A1GFERSMN1; SMN2KDM4E
SCHEMBL16181825 0.86 GAA (0.56) POLBALDH1A1GFERKDM4EL3MBTL1
SCHEMBL13559355 0.85 KDM4E (0.40) POLBALDH1A1GFERKDM4EL3MBTL1
SCHEMBL13559348 0.85 SIGMAR1 (0.44) ALDH1A1GFERKDM4EL3MBTL1MEN1
SCHEMBL13559336 0.85 MEN1 (0.49) POLBNPC1ALDH1A1ATMSMN1; SMN2
SCHEMBL16181808 0.85 OPRM1 (0.43) ALDH1A1GFERKDM4EL3MBTL1MEN1
SCHEMBL13559366 0.84 CYP1A2 (0.41) ALDH1A1GFERKDM4EL3MBTL1MEN1
SCHEMBL13559367 0.84 KDM4E (0.39) POLBALDH1A1GFERKDM4EL3MBTL1
SCHEMBL13985382 0.84 SIGMAR1 (0.50) ALDH1A1HTTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170848-B1 PYRAZINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF LUNG DISEASES ASTRAZENECA AB (SE) 2014-10-22 EP disclosed